KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 158 filers reported holding KRYSTAL BIOTECH INC in Q4 2022. The put-call ratio across all filers is 6.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11 | 0.0% | 96 | 0.0% | 0.00% | – |
| Q2 2023 | $11 | +37.5% | 96 | 0.0% | 0.00% | – |
| Q1 2023 | $8 | 0.0% | 96 | 0.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 96 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 96 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +20.0% | 96 | +26.3% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 76 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 76 | +76.7% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 43 | +16.2% | 0.00% | – |
| Q4 2020 | $2,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |